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Vitreoretinal surgeriesAbstract Purpose: The purpose of this study was to compare the effect of adding different doses
of dexmedetomidine to local anesthetic mixture for peribulbar block in vitreoretinal surgeries as
regards duration, efficacy and pain relief.
Materials and methods: In this prospective randomized double blind clinical study, 160 patients
were equally divided into four groups: Group C (the control group) (n= 40) received 10 ml mixture
of lidocaine 2% and bupivacaine 0.5% with 120 IU of hyaluronidase, group D15 (n= 40) received a
10 ml mixture of lidocaine 2% and bupivacaine 0.5% with 120 IU of hyaluronidase + 15 lg
dexmedetomidine, group D20 (n= 40) received a 10 ml mixture of lidocaine 2% and bupivacaine
0.5% with 120 IU of hyaluronidase + 20 lg dexmedetomidine and group D25 (n= 40) also
received a 10 ml mixture of lidocaine 2% and bupivacaine 0.5% with 120 IU of hyaluronidase
+ 25 lg dexmedetomidine.
The onset of globe anesthesia and akinesia and their duration, the intraocular pressure (IOP),
patient comfort and surgeon satisfaction were all assessed.
Data were analyzed and the results were presented as mean ±SD (Standard Deviation) and
Ranges, number (%) and median (IQR) (Inter quartile range). Chi-square test (x2) was used to
compare nonparametric variables. Comparison between groups was done using Analysis of Vari-
ance (ANOVA-One Way) as a parametric test and Kruskal Wallis Analysis of Variance by ranks
as a nonparametric test. P values less than 0.05 (p< 0.05) was considered to be significant.
Results: The onset of globe anesthesia was shorter in dexmedetomidine groups in comparison with
control group. The difference was statistically significant in group D25 and group D20 in compar-
ison with the control group (p> 0.05). Regarding the duration of globe analgesia, adding
dexmedetomidine to the local anesthetic mixture prolonged the duration of globe analgesia, and this
difference was statistically significant in group D25 in comparison with the control group
(p> 0.05). Regarding the duration of globe akinesia although there was prolongation of the
574 M. Hafez et al.duration of akinesia in all groups the difference was statistically significant only in group D25 when
compared to the control group (p> 0.05). The Verbal Rating Score (VRS) during surgery didn’t
show any significant difference when comparing the dexmedetomidine groups (D15, D20 and
D25) to the control group or when comparing the four groups to each other (p< 0.05).
Conclusions: Adding dexmedetomidine to a mixture of lidocaine 2% and bupivacaine in peribulbar
block shortened sensory and motor block onset, extended the analgesia period and the motor block
duration. It also significantly decreased the intraocular pressure and enabled better operating con-
ditions. In this study, the addition of 25 l dexmedetomidine to the local anesthetic mixture showed
the best outcome.
 2016 Publishing services by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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Patient comfort, safety and low complication rates are the
essentials of local anesthesia in ophthalmic surgery. Vitreoreti-
nal surgeries are known to be lengthy surgeries and painful
especially during specific steps of the surgery.
Many adjuvants were tried before to help to improve the
potency of the block and increase the duration of analgesia
and akinesia intra- and post-operatively [1,2].
Dexmedetomidine was used before in neuroaxial blocks
and regional blocks and proved to decrease the onset of anes-
thesia and akinesia and increase the duration of analgesia and
akinesia in all these blocks [3].
In this study we tried small doses of dexmedetomidine as
adjuvants with tight range increments in combination with
the usual mixture of the local anesthetics used in peribulbar
block (15 lg, 20 lg and 25 lg) comparing it with a control
group to detect precisely which dose was the best.
2. Methods
After obtaining approval from The Ethics and Research Com-
mittee of the Research Institute of Ophthalmology, written
informed consent was taken from 160 adult patients, scheduled
for elective vitreoretinal surgery under local anesthesia, whom
were included in this prospective double-blinded, randomized
clinical trial. Inclusion criteria included patients with axial
length 22–28 mm, and ages ranged between 40 and 80 years.
Patients were ASA I-III. Method of randomization was closed
envelope. These patients were randomly allocated into four
equal groups:
Group C (the control group) (n= 40) received 10 ml mixture
of lidocaine 2% and bupivacaine 0.5% with 120 IU of
hyaluronidase.Group D15 (n= 40) received a 10 ml mixture of lidocaine
2% and bupivacaine 0.5% with 120 IU of hyaluronidase
+ 15 lg dexmedetomidine.
Group D20 (n= 40) received a 10 ml mixture of lidocaine
2% and bupivacaine 0.5% with 120 IU of hyaluronidase
+ 20 lg dexmedetomidine.
Group D25 (n= 40) also received a 10 ml mixture of lido-
caine 2% and bupivacaine 0.5% with 120 IU of hyaluroni-
dase + 25 lg dexmedetomidine.
All patient received peribulbar block by an experienced
anesthesiologist, and both patient and anesthesiologist were
blinded to the drug mixture used.
Exclusion criteria included coagulation problems, commu-
nication problems, allergy to dexmedetomidine or local anes-
thetic, patients receiving adrenergic blockers or having heart
block, high myopia (axial length more than 28 mm) and
staphylomas.
On arrival to operating room, a vein was cannulated and
the arterial blood pressure was measured with an automated
oscillometer, 5 leads electrocardiography was connected and
arterial oxygenation was measured by a pulse oximetry.
Each patient received 10 ml of the anesthetic mixture
according to his/her group. The patient was asked to fix his
eyes looking straight forward toward the ceiling while lying
in a supine position. A 10 ml syringe with a 25G needle was
used for the local anesthetic injection. After negative aspira-
tion, the first 5 ml was slowly injected as lateral as possible
the inferior orbital margin with the bevel directed toward the
equator of the eye ball and the other 5 ml was given between
the caruncle and the medial canthus.
Intermittent gentle massage was applied for 10 min. After
satisfactory sensory and motor block, oxygen 3 L/min was
delivered through a nasal cannula to the patient. Surgery
was then allowed to proceed.
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at the time of the block or during the intraoperative period.
Ephedrine and atropine were available to be given when-
ever decreased mean arterial pressure (MAP) or heart rate
more than 20% of the patient’s baseline reading had occurred
respectively, as a side effect to any systemic absorption of the
dexmedetomidine.
Atropine 1 mg/ml, diluted with saline to a con-
centration of 0.1 mg/ml and given 0.01 mg/kg if
bradycardia and ephedrine 30 mg/ml diluted with
saline to a concentration of 3 mg/ml if
hypotension.
Sedation levels: were monitored on a 4-point scale
(0 = alert, 1 = drowsy, 2 = asleep but easily aroused,
3 = comatose) and were checked every 15 min during the pro-
cedure and every 30 min during the first two postoperative
hours [1].
Verbal Rating Scale (VRS): Intraoperative pain was
assessed every 30 min intervals from the onset of the surgical
intervention till its end and postoperative pain was assessed
every 2 h for 6 h after the operation by a 5-point VRS
(0 = no pain, 1 = mild pain, 2 = moderate pain, 3 = severe
pain and 4 = unbearable pain).
Patient was asked to rate pain whenever felt during surgery
or in the postoperative period and express it in numbers corre-
sponding to the VRS. Intraoperatively, if pain (VRS = 3 or 4)
was reported, supplement local anesthetic mixture (2 ml lido-
caine + 2 ml bupivacaine) will have been given by a medial
canthal injection. Postoperatively, diclofenac intramuscular
injection or intravenous infusion will be given once pain was
reported.
Hemodynamic monitoring: The heart rate and MAP were
assessed before the peribulbar block (Baseline reading),
15 min after injection and every 30 min during the surgery.
Complications and side effects: Local and systemic compli-
cations related to the technique and the drugs used were
monitored.
Patient comfort: Intraoperative and postoperative patient
comforts were assessed using 2 scale simple questionnaire
(1 = comfortable, 0 = uncomfortable).
Surgeon satisfaction: Surgeons were asked about their con-
venience with the anesthesia during surgery using also a 2 scale
simple questionnaire (1 = satisfied, 0 = unsatisfied).Table 1 Demographic characteristics, duration of surgery, surgeon
Group C (N= 40) Group D15 (N=
Age years 44 ± 15.72 47 ± 12.90
Gender
 Male n (%) 28 (70) 30 (75)
 Female n (%) 12 (30) 10 (25)
Duration of surgery (min) 111 ± 30 110 ± 35
Surgeon’s satisfaction
 Satisfied n (%) 29 (72) 30 (75)
 Not satisfied n (%) 11 (28) 10 (25)
Patient’s comfort
 Satisfied n (%) 35 (87.5) 37 (92.5)
 Non-satisfied n (%) 5 (12.5) 3 (7.5)
Ordinal data are expressed as Mean ± SD, nominal data are expressed a2.1. Sample size calculation
Power analysis was performed using one way Analysis of Vari-
ance (ANOVA) on duration of sensory block because it was
the main outcome variable in the present study. A previous
study [3] showed that the standard deviation of duration of
sensory block was about 57 min with a mean of 187 min. Based
upon the assumption that adding dexmedetomidine to local
anesthetic prolongs the duration of sensory block by 20%
and taking power 0.8 and alpha error 0.05, a minimum sample
size of 38 patients was calculated for each group. A total of
patients in each group 40 were included to compensate for pos-
sible dropouts.
3. Results
One hundred and sixty adult patients who had undergone elec-
tive vitreoretinal eye surgery under peribulbar block were
included in this study. These patients were divided randomly
into four equal groups by closed envelopes, Groups D15,
D20 and D25 who received 15, 20 and 25 l dexmedetomidine
adjuvant to peribulbar local anesthetic mixture respectively
and a control group that received the local anesthetic mixture
only. The demographic characteristics including age, gender
and duration of surgery did not show any statistical significant
difference between the four groups (Table 1).
Regarding the block characteristics
The onset of globe anesthesia, was shorter in dexmedetomidine
groups in comparison with control group. The difference was
statistically significant in group D25 and group D20 in com-
parison with the control group (p> 0.05) (Table 2).
Regarding the onset of globe akinesia, however adding
dexmedetomidine to the block shortened the onset of globe
akinesia in dexmedetomidine groups (Table 2).
The lid akinesia score showed no statistical significant dif-
ference in between groups when compared together or when
compared to Group C. (Table 2).
Regarding the duration of globe analgesia, adding
dexmedetomidine to the local anesthetic mixture prolonged
the duration of globe analgesia (group D25 260 min, group’s and patient’s satisfaction.
40) Group D20 (N= 40) Group D25 (N= 40) P value
50.7 ± 15.32 50.9 ± 12.70 0.556
31 (77.3) 27 (68.2) 0.778
9 (22.7) 13 (31.8)
103 ± 40 122 ± 37 0.23
31 (77.3) 35 (87.5) 0.596
9 (22.7) 5 (12.5)
38 (95) 38 (95) 0.4
2 (5) 2 (5)
s frequencies (%). P< 0.05 is considered significant.
Table 2 Block characteristics.
Group C (N= 40) Group D15 (N= 40) Group D20 (N= 40) Group D25 (N= 40) P value
Onset of anesthesia (min) 2.5 (2,3.7) 1.8 (1.5,3) 1.55 (1.3,2.8)* 1.3 (1.05,2.6)* 0.03
Onset of akinesia (min) 10.5 (9,12.3) 9 (8,11.1) 8.3 (6.5,10.8) 8 (6.3,10) 0.05
Duration of analgesia (min) 179 (107,197) 192 (122,221) 227 (154,247) 260 (178,284)* 0.01
Duration of akinesia (min) 122 (101,147) 149 (122,165) 150 (125,175) 170 (132,195)* 0.01
Lid Akinesia score
 1 25 (62.5%) 29 (72.5%) 29 (72.5%) 30 (75%) 0.39
 2 12 (30%) 11 (27.5%) 10 (25%) 9 (22.5%)
 3 3 (7.5%) 0 (0%) 1 (2.5%) 1 (2.5%)
Sedation level
 0 alert 40 (100%) 40 (100%) 40 (100%) 40 (100%) 1.00
 1 drowsy 0 (0%) 0 (0%) 0 (0%) 0 (0%)
 2 asleep 0 (0%) 0 (0%) 0 (0%) 0 (0%)
 3 comatose 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Ordinal data expressed as median (IQR), while nominal data is expressed as frequency (%).
P value > 0.05 is considered significant.
* Denotes statistical significance compared to group C.
576 M. Hafez et al.D20 227 min, group D15 192 min and the control group
179 min). This difference was statistically significant in group
D25 in comparison with the control group (p> 0.05). How-
ever no statistical significant difference was detected when
comparing group D20 or group D15 to the control group.
Also, the comparison between the three dexmedetomidine
groups showed no statistical significant difference (Table 2).
Regarding the duration of globe akinesia, although there
was prolongation of the duration of akinesia in all groups
(group D25 170 min, group D20 150 min, group D15
149 min and Group C 122 min) the difference was statistically
significant only in group D25 when compared to the control
group P value < 0.05. No significant difference was detected
when comparing group D25 to D20 or D15 (Table 2).
Effect on intra-ocular pressure (IOP) in mmHg
Within the same group a statistically significant decrease in
the IOP was detected when comparing IOP 5 min andTable 3 Intra Ocular Pressure (IOP) in mmHg.
Group C Group D15
IOP BL 16.05 ± 1.3 15.7 ± 1.22
IOP 5 min 14 ± 1.89 13.5 ± 2.08
IOP 10 min 12.89 ± 3.13 12.6 ± 2.04
Data are presented as Mean ± SD.
IOP: Intraocular pressure, BL: Baseline.
* Denotes significance compared to the same reading in group C.
– Denotes significance compared to the baseline reading in the same gro
Table 4 Intraoperative VRS.
Group C Group D15
Starting Surgery 0 (0,0) 0 (0,0)
30 min 0 (0,0) 0 (0,0)
60 min 0 (0,0) 0 (0,0)
90 min 0 (0,1) 0 (0,1)
120 min 0 (0,1) 0 (0,1)
Ordinal data represented as median (IQR), VRS: Verbal Rating Scale.P10 min in Group D25 to the baseline measurement (p
value = 0.01), while no significant differences were detected
when comparing the IOP5 min and 10 min to the baseline
measurement in any other group (Groups C, D15 and D20).
Also, a statistically significant decrease was detected when
comparing IOP5 min and 10 min in Group D25 to the same
readings in the Group C, while no significance was found
comparing the same measurements in Groups D15 and D20
to Group C (Table 3).
Regarding the assessment of Pain Intra-and Post-operative:
The VRS during surgery didn’t show any significant difference
when comparing the dexmedetomidine groups (D15, D20 and
D25) to the control group or when comparing the four groups
to each other (p< 0.05) (Tables 4 and 5).
There was no change in the sedation level after the peribul-
bar block and during the whole surgery in any of the four
groups in comparison with the pre-block state (Table 2).
Regarding the hemodynamic monitoring (the mean HR and
MAP), there was no significant difference within all groupsGroup D20 Group D25 P value
15.35 ± 1.27 15.4 ± 1.53 0.3
13.1 ± 2.7 12.45 ± 2.08*,– 0.01
11.95 ± 1.66 11 ± 1.64*,– 0.01
up.
Group D20 Group D25 P value
0 (0,0) 0 (0,0) 0.7
0 (0,0) 0 (0,0)
0 (0,0) 0 (0,0)
0 (0,1) 0 (0,0)
0 (0,1) 0 (0,1)
> 0.05 is considered significant.
Table 5 Postoperative VRS.
Group C Group D15 Group D20 Group D25 P value
Immediate postoperative 0 (0,1) 0 (0,1) 0 (0,1) 0 (0,1) 0.2
1 h 0 (0,0) 0 (0,0) 0 (0,1) 0 (0,1)
2 h 1 (0,2) 0 (0,0) 0 (0,1) 0 (0,1)
4 h 1 (0,2) 1 (0,2) 1 (0,2) 0 (0,1)
6 h 2 (1,3) 2 (1,3) 1 (0,2) 1 (0,2)
Ordinal data represented as median (IQR), VRS: Verbal Rating Scale.P> 0.05 is considered significant.
Table 6 Mean HR (Beat/min).
Group C Group D15 Group D20 Group D25 P value
Baseline 76(±13) 88(±15) 78(±9) 72(±13) 0.7
15 min after injection 74(±13) 86(±15) 75(±9) 71(±14)
30 min after onset of surgery 73(±13) 84(±15) 74(±9) 70(±13)
60 min 72(±13) 84(±15) 73(±9) 72(±13)
90 min 72(±13) 83(±15) 72(±9) 74(±13)
120 min 71(±14) 82(±15) 70(±9) 75(±13)
Ordinal data expressed as Mean ± SD. HR: Heat rate.
P value > 0.05 is considered significant.
Table 7 Mean MAP (mmHg).
Group C Group D15 Group D20 Group D25 P value
Baseline 99(±13) 103(±16) 80(±12) 96(±16) 0.6
15 min after injection 103(±13) 98(±16) 78(±12) 92(±16)
30 min after onset of surgery 100(±13) 96(±16) 77(±12) 91(±15)
60 min 97(±13) 92(±16) 77(±12) 93(±16)
90 min 95(±13) 91(±15) 76(±12) 96(±16)
120 min 94(±13) 93(±16) 76(±12) 98(±16)
Ordinal data expressed as Mean ± SD. MAP: mean arterial pressure.P value > 0.05 is considered significant.
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groups to the control group (Table 6 and 7).
Regarding the patient’s comfort, Thirty-seven (92.5%)
patients in Group D15, 38 (95%) patients in Group D20, 38
(95%) patients in Group D25 and 35(87.5%) patients in
Group C were comfortable during operation. (Table 1) Sur-
geons were satisfied in 30 patients (75%) in Group D15, 31
patients (77.3%) in Group D20, 35 patients (87.5%) in Group
D25 and 29 patients (72%) in Group C (Table 1).
4. Discussion
The results of this study showed that addition of 25 lg
dexmedetomidine to a mixture of lidocaine 2% and bupiva-
caine 0.5% to peribulbar block shortened the onset of sensory
and motor block, increased the duration of postoperative anal-
gesia, duration of akinesia and decreased the IOP in a statisti-
cally significant way. Peribulbar block is commonly used for
vitreoretinal surgery in adult, but using only local anesthetics
for peribulbar anesthesia is usually associated with delayed
onset of globe akinesia and corneal anesthesia [4], short dura-
tion of analgesia and frequent need of block supplementation
[5].
To decrease the time of onset of action and increase the
duration of analgesia, many additives [6] such as adrenaline,sodium bicarbonate and clonidine were added to local anes-
thetics. Dexmedetomidine is centrally acting, highly specific
a2 agonist, and the principal mechanism for the analgesic
action is spinal, even though there is a clear evidence for both
supraspinal and peripheral sites of action [7]. The exact mech-
anism by which a2 adrenergic receptor agonists produce anal-
gesia and sedation is not fully understood but it is likely to be
multifactorial [8]. Peripherally, a2-agonists reduce the release
of norepinephrine and cause a2 receptor independent inhibi-
tory effects on nerve fiber action potentials. Centrally, a2-
agonists inhibit substance P in the nociceptive pathway at
the level of the dorsal root neuron and activate a2 adrenocep-
tors in the locus coeruleus [8,9]. So, activation of the a2 recep-
tors will inhibit the release of norepinephrine, terminating the
propagation of pain signals. Postsynaptic activation of a2
adrenoceptors in the central nervous system inhibits the sym-
pathetic activity and thus can decrease the blood pressure
and HR [10].
Dexmedetomidine is widely used for sedation and analgesia
during the entire perioperative period: as a premedication [11],
an anesthetic adjunct for general and regional anesthesia [12],
and as a postoperative sedative and analgesic [11–13].
This study was conducted to evaluate the effect of adding
dexmedetomidine to LA mixture for peribulbar block in vitre-
oretinal surgeries, as a trial to decrease the volume of local
578 M. Hafez et al.anesthetics used in the peribulbar block without affecting the
block characteristics, as the larger the volume injected the
higher the risks of increased IOP and intraorbital pressures
and its risks (optic nerve compression, retinal artery occlusion
and higher incidences of myopathies in extraocular muscle)
[14–16].
In this study, one hundred and sixty patients were allocated
in four equal groups (40 each), group C (control group), group
D15 (15 lg added to the LA mixture), group D20 (20 lg added
to the LA mixture) and group D25 (25 lg added to the LA
mixture). In this study the onset of corneal anesthesia in group
D25 was significantly shorter than in the control group
(p< 0.05), whereas the onset of globe akinesia showed no sta-
tistical significant difference between group D25 and control
group (p> 0.05). Also there was statistically significant
decrease in the onset of analgesia between group D20 and con-
trol group (p< 0.05).
Channabasappa et al. [3] evaluated the effect of adding two
different doses (25 lg and 50 lg) of dexmedetomidine to the
lidocaine/bupivacaine mixture for peribulbar block in cataract
surgeries. They reported that the onset of corneal anesthesia
and globe akinesia was significantly shorter in group D50 than
in the control group. In group D25, the onset of corneal anes-
thesia was significantly shorter than the control group but not
the globe akinesia. These findings were coinciding with the
results of this study regarding the onset of corneal anesthesia
and globe akinesia in group D25.
Whereas in another study by Hala et al. [17], who studied
the effect of adding two different doses of dexmedetomidine
(25 lg and 50 lg) to levobupivacaine/hyaluronidase mixture
and assessed their effects on the onset and duration of globe
anesthesia and akinesia, they found out that the onset of cor-
neal anesthesia and globe akinesia in group D25 was shorter
than in the control group but the difference was not statisti-
cally significant [17].
In this study, the onset of corneal anesthesia in group D15
and the onset of globe akinesia in group D15 and D20 showed
no statistically significant difference in comparison with the
control group (p> 0.05). The use of a2 agonists as adjuvants
to local anesthetics in ophthalmic regional blocks was started
with the use of clonidine.
Madan et al. [18], compared the effect of clonidine added to
lidocaine/hyaluronidase mixture in peribulbar block in three
different doses (0.5 lg/kg, 1 lg/kg and 1.5 lg/kg) at the onset
and duration of globe anesthesia and akinesia. They found
that there was no statistically significant difference in between
the three groups or when comparing each group to the control
group regarding the onset of globe anesthesia or akinesia.
Reem et al. [19] compared the two a2 agonists (clonidine
versus dexmedetomidine) in peribulbar block. They studied
two groups of patients: one group received a mixture of lido-
caine/bupivacaine/1 lg/kg clonidine and the other received
lidocaine/bupivacaine/1 lg/kg dexmedetomidine. There was
no statistical significance between the two groups regarding
the onset of globe anesthesia and akinesia.
Regarding the lid akinesia score in this study, there was no
statistically significant difference between the four groups
(control group, D15, D20 and D25) (p> 0.05). Regarding
the duration of analgesia, in this study there was a statistical
significant difference between group D25 and the control
group (p< 0.05) whereas there was no significant difference
between groups D15, D20 and the control group. These find-ings were similar to the results in Hala et al’s [17] study where
time to first rescue analgesia in their study was significantly
longer in patients receiving 50 lg and 25 lg dexmedetomidine
added the levobupivacaine/hyaluronidase mixture compared
to patients receiving the anesthetic mixture alone. Channabas-
appa et al. [3] also found statistically significant longer dura-
tion of analgesia in patients receiving 50 lg and 25 lg
dexmedetomidine added to lidocaine/bupivacaine mixture
compared with the patients who received mixture of only local
anesthetics. In this study, the duration of akinesia showed a sta-
tistical significant difference between group D25 and the con-
trol group (p< 0.05). On the other hand, there was no
significant difference between groups D15 and D20 and the
control group (p> 0.05) or in between the dexmedetomidine
groups. Similarly, Hala et al. [17] and Channabasappa et al.
[3] found out that patients who received 25 lg dexmedeto-
midine added to their anesthetic mixture used in the peribulbar
block, showed a statistically significant increase in the duration
of akinesia compared to the group of patients who received
only the local anesthetic mixture. In this study, the duration
of akinesia in group D25 was 170 min (112,195) whereas in
the study by Channabasappa et al. [3] the duration in group
D25 was 193 min ± 27.69 and in the study by Hala et al.
[17] in group D25 was 197 min ± 25.95. The explanation of
this difference between the three studies regarding the duration
of akinesia, lies in the component of the anesthetic mixture
used in each study. In this study lidocaine/bupivacaine/hyalur
onidase mixture was used whereas Hala et al. [17] used
levobupivacaine/hyaluronidase only so they replaced the short
duration lidocaine volume with levobupivacaine while in the
study by Channabasappa et al. [3] they used lidocaine/bupiva-
caine only without hyaluronidase, so the spread of the local
anesthetics needed more time. But these clinically significant
differences were not noticed regarding the duration of
analgesia.
Also, Madan et al’s [18] study found that the duration of
globe analgesia and akinesia was significantly prolonged in
patients receiving 1.0 and 1.5 lg/kg clonidine with lidocaine/
hyaluronidase mixture when compared to the patients who
received the lidocaine/hyaluronidase mixture alone. In Reem
et al’s [19] study, the duration of globe analgesia and globe aki-
nesia showed a statistically significant increase in both groups
of study (the clonidine group and dexmedetomidine group) in
comparison with the control group.
Regarding the IOP, the addition of dexmedetomidine to the
local anesthetic mixture in group D25 showed a statistically
significant decrease in the IOP 5 min and 10 min after the
injection of the local anesthetic mixture when comparing to
the baseline measurement of the same group (12.45 ± 2.08,
11 ± 1.64 and 15.4 ± 1.53 respectively) (p< 0.05). Also sig-
nificant decrease was detected when comparing IOP 5 min
and 10 min in Group D25 to the same readings in Group C
(12.45 ± 2.08, 11 ± 1.64 and 14 ± 1.89, 12.89 ± 3.13 respec-
tively) (p< 0.05), while no significant differences were
detected when comparing the IOP5 min and 10 min to the
baseline measurement in any other group (Groups C, D15
and D20) nor when comparing the same readings in Group
D15 and Group D20 to Group C. These results were correlat-
ing with those of Hala et al. [17] and Channabasappa et al. [3]
where they found that the addition of dexmedetomidine to LA
mixture (groups D25 and D50) caused a statistically significant
decrease in IOP compared to control group at 1, 5, and 10 min
Peribulbar block in vitreoretinal surgeries 579after injection. In the study by Reem et al. [19], there was a sig-
nificant difference between the clonidine group and the
dexmedetomidine group regarding the IOP measurements
5 min and 10 min after injection.
5. Conclusions
Adding dexmedetomidine to a mixture of lidocaine 2% and
bupivacaine in peribulbar block shortened sensory and motor
block onset, and extended the analgesia period and the motor
block duration. It also significantly decreased the intraocular
pressure and enabled better operation conditions. In this
study, the addition of 25 l dexmedetomidine to the local anes-
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